SCHEMBL7267812

SCHEMBL7267812

COc1cc2c(N3CCOCC3)nc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)nc2c(OC)c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 3/20 0.47
▸ PIK3CD O00329 2/20 0.47
▸ PIK3R1 P27986 2/20 0.47
▸ PIK3CB P42338 2/20 0.47
▸ PIK3CG P48736 2/20 0.47
▸ PIK3R5 Q8WYR1 2/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ HPGD P15428 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ CYP3A4 P08684 3/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CLK4 Q9HAZ1 1/20 0.43
▸ PDE10A Q9Y233 1/20 0.42
▸ KDM4E B2RXH2 4/20 0.41
▸ TSHR P16473 3/20 0.41
▸ HSD17B10 Q99714 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7262638 0.89 SMN1; SMN2 (0.45) SMN1; SMN2HPGDALDH1A1CYP3A4CYP1A2
SCHEMBL7261507 0.82 ALDH1A1 (0.52) PIK3CAPIK3CDPIK3R1PIK3CBPIK3CG
SCHEMBL5259886 0.78 HPGD (0.40) SMN1; SMN2HPGDALDH1A1CYP3A4CYP1A2
SCHEMBL5258158 0.77 GAA (0.40) SMN1; SMN2HPGDALDH1A1CYP3A4CYP1A2
SCHEMBL7267780 0.75 HPGD (0.67) PIK3CAPIK3CDPIK3R1PIK3CBPIK3CG
Hydrochloric Acid SCHEMBL8375906 0.73 PDE10A (0.64) PIK3CASMN1; SMN2ALDH1A1HIF1ACYP3A4
SCHEMBL7268690 0.71 PDE1B (0.57) SMN1; SMN2HPGDALDH1A1CYP3A4MAPK1
SCHEMBL7262055 0.70 TGFBR1 (0.43) SMN1; SMN2HPGDALDH1A1HIF1AUSP2
SCHEMBL7268671 0.70 AURKA (0.45) PIK3CAPIK3CDPIK3R1PIK3CBPIK3CG
SCHEMBL7261986 0.69 NPSR1 (0.47) SMN1; SMN2HPGDALDH1A1HIF1ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613772-B1 Drugs such as 2-(p-chlorophenyl-4-(4-hydroxybutyl)amino-6,7,8 -trimethoxyquinazoline used for activation of guanylate cyclase and modulation of cyclic guanosine monophosphate AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-02 — — US disclosed
EP-1040101-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Aventis Pharma Deutschland GmbH (DE) 2000-10-04 — — EP disclosed
WO-1999032460-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-01 — — WO disclosed
Send feedback